Navigation Links
Leading Physicians To Host Medical Device Related Infection Prevention CME Webcast

Rabih Darouiche, MD and Charles Love, MD to Present Live Webcast: 'New Standards of Care for CRMD Antibiotic Protection'

MONMOUTH JUNCTION, N.J., Nov. 12 /PRNewswire/ -- TYRX, Inc., a leader in the development and commercialization of combination drug-device products, announced today that it has provided a grant for a complimentary live CME webcast hosted by leading physicians entitled, "New Standards of Care for CRMD Antibiotic Protection." The Interactive Web Symposia will be presented live on November 18, 2008 at 6:00 p.m. EST and November 19, 2008 at 3:00 p.m. EST by Rabih O. Darouiche, MD and Charles J. Love, MD.

Dr. Darouiche, VA Distinguished Service Professor, Director, Center for Prostheses Infection, Baylor College of Medicine (Houston, TX), will present on the topic: "Prevention of Device-Related Infections." Dr. Love, Professor of Clinical Medicine, Division of Cardiovascular Medicine, Ohio State University Medical Center and Director, Arrhythmia Device Services and Associate Investigator, Dorothy M. Davis Heart & Lung Research Institute (Columbus, OH), will present the topic: "Current Trends in Implantable Device Infection and Management."

The program is designed to educate physicians, nurses and technologists to: address the pathogenesis of infections associated with pacemakers; and cardioverter defibrillators; assess the anti-infective efficacy of potentially preventive approaches; and describe the risks and costs associated with resolving device-related infections. Participants can register at the following web link:

"This CME program will provide participants with valuable information on a timely and important topic in the medical device and broader healthcare community," said Bill Edelman, CEO of TYRX, Inc. "The CDC estimates that approximately one million hospital acquired infections each year are associated with indwelling devices and CMS has indicated that CRMD devices may be added to the no-pay list in 2010. This webcast will provide electrophysiologists and cardiac surgeons with valuable tools to help protect their patients, reduce implant infections and save unnecessary hospital costs. We are honored to provide a grant that enables Drs. Darouiche and Love, two of the most renowned experts in their fields, to address the topic of surgical site infection prevention."

Participants will be provided with access instructions via email prior to the live presentation. A score of 70 percent or above will comprise a passing grade. A documentation of credit will be awarded to participants who successfully complete the exam. Those who successfully complete the post-test and evaluation form online may immediately print their documentation of credit. Physicians and nurses will be able to register online and complete the program for credit for one year following the webcast.

This activity is sponsored by the North American Center for Continuing Medical Education (NACCME). NACCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(TM).

NACCME is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. This continuing nursing education activity was approved by the PA State Nurses Association for 1 contact hour (Provider Number 110-3-E-06). Provider approved by the California Board of Registered Nursing, Provider Number 13255, for 1 contact hour.

About TYRX, Inc.

TYRX, Inc. is a global leader in the development of novel combination drug-device products that address surgical site infections (SSIs) across a broad range of surgical applications, including general, cardiovascular and cosmetic-surgical markets. TYRX's lead product platform, AIGISRx CRMD (cardiac rhythm management device), is a 510k cleared antimicrobial surgical mesh designed to deliver site specific therapy to prevent SSIs following CRMD implantation. The combination medical products sector (products incorporating both a drug and a device component) is expected to be the highest growth segment of the medical products industry, and TYRX is positioned to be an innovative leader in this space.

TYRX, an IS0 9001:2000 and IS0 13485:2003 certified medical device manufacturer, has exclusively licensed product patents and associated technologies from Rutgers, The State University of New Jersey, Baylor College of Medicine and The University of Texas M.D. Anderson Cancer Center. More information may be found at


Bill Edelman

President and CEO

TYRX, Inc.


Media Contact:

Jennifer Saunders

The Ruth Group

646.536. 7011

Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
4. Leading-edge body sensor could help produce sporting champions
5. Hospital Quality Info on Web Can Be Misleading
6. AT&T Establishes New Network Services for Leading Medical Liability Insurer
7. Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nations Preparedness for Disasters
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. Sentillion Positioned in Visionaries Quadrant in Leading Industry Analyst Firms User Provisioning Magic Quadrant
10. Leading Asthma and Allergy Author and Counselor Joins The HealthCentral Network As Expert
11. Long Term Care Insurance Gains Momentum Thanks to State Promotions, a Leading Brokerage Reports
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced its strategic partnership with Connance, a healthcare industry leader providing predictive ... proven, proprietary technology combine to provide health systems, hospitals and ambulatory surgical ...
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... ... 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can ... CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn ... X . Simply select a ProHand generator and drag it above media or text ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016  MedSource announced ... as its e-clinical software solution of choice.  This ... best possible value to their clients by offering ... The preferred relationship establishes nowEDC as the EDC ... for MedSource,s full-service clients.  "nowEDC has long been ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
(Date:6/23/2016)... , June 23, 2016 , ... on Thursday, July 7, 2016 , , , , LOCATION: ... , , , , EXPERT PANELISTS:  , , , ... Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and ... The global pharmaceutical industry is witnessing an exceptional era. ...
Breaking Medicine Technology: